12个月体积缩小率预测激光消融后甲状腺结节的再生长及再生长时间:一项5年随访回顾性研究
该回顾性研究纳入104例接受激光消融的良性实性冷甲状腺结节患者并随访5年,发现12个月体积缩小率(VRR)<50.0%者占29.8%,37.5%出现结节再生长;12个月VRR越低,再生长风险越高且再生长时间越短,非海绵状结构亦增加再生长风险。
要点
- 12个月VRR<50.0%是再生长预测风险因素,OR 11.7(95%CI 4.2-32.2;p<0.001)。
- 非海绵状结构结节再生长风险增高,OR 4.3(95%CI 1.8-10.2;p<0.001)。
- 12个月VRR越低,再生长风险越高且再生长时间越短(p<0.001;R²=0.3516)。
核心结论
- 接受相似激光能量的甲状腺结节其VRR差异很大,并取决于结节结构;非海绵状结节缩小程度较小且较海绵状结节更常再生长。
- 12个月VRR<50.0%是再生长的预测风险因素,并与再生长时间相关。
研究设计与样本
- 回顾性研究,纳入104例良性、实性、冷甲状腺结节接受激光消融并随访5年的患者。
- 基线结节体积中位数12.5 mL(25.0-75.0%,8-18 mL),递送能量中位数481.5 J/mL(25.0-75.0%,370-620 J/mL)。
- 在基线和术后每年评估结节体积、甲状腺功能试验和超声。
关键影像表现/征象
- 104例中31例(29.8%)12个月VRR<50.0%,39例(37.5%)发生结节再生长。
- 39例再生长患者中17例(43.6%)接受手术,14例(35.9%)接受第二次激光治疗。
- 结节再生长率与12个月VRR呈负相关,即12个月VRR越低,再生长风险越高(p<0.001)。
- 结节再生长平均时间为33.5±16.6个月。
诊断标准与关键数值
- 12个月VRR<50.0%预测再生长的OR为11.7(95%CI 4.2-32.2;p<0.001)。
- 非海绵状结构预测再生长的OR为4.3(95%CI 1.8-10.2;p<0.001)。
- 12个月VRR与再生长时间直接相关,即12个月VRR越低,再生长时间越短(p<0.001;R²=0.3516)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Laser ablation is a therapeutic modality used to reduce the volume of large benign thyroid nodules. Unsatisfactory reduction and regrowth are observed in some treated nodules. The aim of the study was to evaluate the long-term outcomes of laser treatment for solid nodules during a 5-year follow-up period, the regrowth rate, and the predictive risk factors of nodule regrowth.
MATERIALS AND METHODS: We retrospectively evaluated patients with benign, solid, cold thyroid nodules who underwent laser ablation and were followed-up for 5 years. According to the selection criteria, 104 patients were included (median baseline nodule volume, 12.5 mL [25.0-75.0%, 8-18 mL]; median energy delivered, 481.5 J/mL [25.0-75.0%, 370-620 J/mL]). Nodule volume, thyroid function test results, and ultrasound were evaluated at baseline and then annually after the procedure.
RESULTS: Of 104 patients, 31 patients (29.8%) had a 12-month volume reduction ratio (VRR) < 50.0% and 39 (37.5%) experienced nodule regrowth. Of these 39 patients, 17 (43.6%) underwent surgery and 14 (35.9%) underwent a second laser treatment. The rate of nodule regrowth was inversely related to the 12-month VRR, i.e., the lower the 12-month VRR, the higher the risk of regrowth (p < 0.001). The mean time for nodule regrowth was 33.5 ± 16.6 months. The 12-month VRR was directly related to time to regrowth, i.e., the lower the 12-month VRR, the shorter the time to regrowth (p < 0.001; R² = 0.3516). Non-spongiform composition increased the risk of regrowth with an odds ratio of 4.3 (95% confidence interval [CI] 1.8-10.2; p < 0.001); 12-month VRR < 50.0% increased the risk of regrowth with an odds ratio of 11.7 (95% CI 4.2-32.2; p < 0.001).
CONCLUSION: The VRR of thyroid nodules subjected to similar amounts of laser energy varies widely and depends on the nodule composition; non-spongiform nodules are reduced to a lesser extent and regrow more frequently than spongiform nodules. A 12-month VRR < 50.0% is a predictive risk factor for regrowth and correlates with the time to regrowth.
引用
- Negro R, Greco G, Deandrea M, et al. Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study. Korean J Radiol. 2020. PMID: 32410415. doi:10.3348/kjr.2019.0798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。